Quote:
Originally Posted by GoodLife
A preprint of a Brazilian study using HCQ and azithromycin shows promising results
Of the 636 symptomatic outpatients, 412 started treatment with hydroxychloroquine and azithromycin and 224 refused medications (control group).
Need for hospitalization was 1.9% in the treatment group and 5.4% in the control group (2.8 times greater) and number needed to treat was 28 (NNT = 28). In those who started treatment before versus after the seventh day of symptoms, the need for hospitalization was 1.17% and 3.2%
Conclusion
Empirical treatment with hydroxychloroquine associated with azithromycin for suspected cases of COVID 19 infection reduces the need for hospitalization
Dropbox - 2020.04.15 journal manuscript final.pdf - Simplify your life |
Goodlife, I am starting to think you really don't care what you bring to the thread. At least have the intellectual honesty to tell the readers something about the study. Like tell them that the patients were never examined. Tell them that exactly zero were tested for COVID which means some of these people with "flu symptoms" had bacterial infections like strep or sinus or bacterial pneumonias. Does it surprise you that people with sinus infections and bacterial pneumonias might get better with antibiotics? It doesn't surprise me.
Perhaps you don't understand the meaning of NNT. It means you have to give the drugs to 28 people to have 1 person benefit. So if only one out of every 28 "sick" patients had an underlying bacterial illness this is exactly what your data should result. This study has absolutely zero meaning in treatment of COVID and by the way, these people forgot to add the zinc which is so important per your posts.